Literature DB >> 11877340

Permeability of porcine blood brain barrier to somatostatin analogues.

Gert Fricker1, Stephanie Nobmann, David S Miller.   

Abstract

1. Transport of a fluorescent somatostatin analogue (NBD-octreotide) across freshly isolated functionally intact capillaries from porcine brain was visualized by confocal microscopy and quantitated by image analysis. 2. Luminal accumulation of NBD-octreotide showed all characteristics of specific and energy-dependent transport. Steady-state luminal fluorescence averaged 2 - 3 times cellular fluorescence and was reduced to cellular levels when metabolism was inhibited by NaCN. 3. The accumulation of NBD-octreotide in capillary lumens was inhibited in a concentration-dependent manner by unlabelled octreotide, by verapamil, PSC-833 and cyclosporin A, potent inhibitors of p-glycoprotein, and by leucotriene C(4), a strong modulator of Mrp2. Conversely, unlabelled octreotide reduced luminal accumulation of fluorescent BODIPY-verapamil on p-glycoprotein and of fluorescein-methotrexate, on Mrp2. None of the inhibitors used significantly reduced cellular accumulation of the fluorescent substrates. 4. Together, the data are consistent with octreotide being transported across the luminal membrane of porcine brain capillaries by both P-gp and Mrp2, providing further evidence that both transporters contribute substantially to the active barrier function of this endothelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877340      PMCID: PMC1573221          DOI: 10.1038/sj.bjp.0704557

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubule.

Authors:  D S Miller; G Fricker; J Drewe
Journal:  J Pharmacol Exp Ther       Date:  1997-07       Impact factor: 4.030

2.  The interaction of some centrally active drugs with the blood-brain barrier and circumventricular organs.

Authors:  D J Begley
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

3.  Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.

Authors:  I H Lelong; A P Guzikowski; R P Haugland; I Pastan; M M Gottesman; M C Willingham
Journal:  Mol Pharmacol       Date:  1991-10       Impact factor: 4.436

4.  Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.

Authors:  W A Banks; A V Schally; C M Barrera; M B Fasold; D A Durham; V J Csernus; K Groot; A J Kastin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Purification of the human intestinal brush border membrane.

Authors:  J Schmitz; H Preiser; D Maestracci; B K Ghosh; J J Cerda; R K Crane
Journal:  Biochim Biophys Acta       Date:  1973-09-27

6.  Carrier-mediated transport of labeled oxytocin from brain to blood.

Authors:  D A Durham; W A Banks; A J Kastin
Journal:  Neuroendocrinology       Date:  1991-05       Impact factor: 4.914

7.  Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization.

Authors:  G Fricker; C Bruns; J Munzer; U Briner; R Albert; T Kissel; J Vonderscher
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

8.  Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.

Authors:  A Tsuji; I Tamai; A Sakata; Y Tenda; T Terasaki
Journal:  Biochem Pharmacol       Date:  1993-09-14       Impact factor: 5.858

9.  Enteral absorption of octreotide: absorption enhancement by polyoxyethylene-24-cholesterol ether.

Authors:  J Drewe; G Fricker; J Vonderscher; C Beglinger
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

10.  Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system.

Authors:  J C Reubi; W Lang; R Maurer; J W Koper; S W Lamberts
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

View more
  13 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

Review 2.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

3.  Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes--a 1H MRS study.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

4.  Development of a Therapeutic Peptide for Cachexia Suggests a Platform Approach for Drug-like Peptides.

Authors:  Kenneth A Gruber; Ren-Lai Ji; Fabio Gallazzi; Shaokai Jiang; Steven R Van Doren; Ya-Xiong Tao; Jessica Newton Northup
Journal:  ACS Pharmacol Transl Sci       Date:  2022-04-14

Review 5.  Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.

Authors:  Dannielle H Upton; Caitlin Ung; Sandra M George; Maria Tsoli; Maria Kavallaris; David S Ziegler
Journal:  Theranostics       Date:  2022-06-06       Impact factor: 11.600

6.  Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Authors:  Maxim Kozhemyakin; Karthik Rajasekaran; Marko S Todorovic; Samuel L Kowalski; Corinne Balint; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-03-05       Impact factor: 5.996

7.  Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells.

Authors:  Salvatore Cisternino; Christophe Rousselle; Aurelio Lorico; Germana Rappa; Jean-Michel Scherrmann
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

Review 8.  Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.

Authors:  Alex M Helman; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2015-12-17

9.  Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions.

Authors:  Michael Török; Jörg Huwyler; Heike Gutmann; Gert Fricker; Jürgen Drewe
Journal:  Exp Brain Res       Date:  2003-09-12       Impact factor: 1.972

10.  Inhibition of P-glycoprotein, multidrug resistance-associated protein 2 and cytochrome P450 3A4 improves the oral absorption of octreotide in rats with portal hypertension.

Authors:  Xiao-Yu Sun; Zhi-Jun Duan; Zhen Liu; Shun-Xiong Tang; Yang Li; Shou-Cheng He; Qiu-Ming Wang; Qing-Yong Chang
Journal:  Exp Ther Med       Date:  2016-10-14       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.